Q4 2025 13F Holders as of 31 Dec 2025
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
49,633,071
-
Total 13F shares
-
97,780
-
Share change
-
-49,935
-
Total reported value
-
$580,879
-
Price per share
-
$5.95
-
Number of holders
-
10
-
Value change
-
-$251,318
-
Number of buys
-
4
-
Number of sells
-
2
Institutional Holders of PUMA BIOTECHNOLOGY, INC. - Common Stock (PBYI) as of Q4 2025
As of 31 Dec 2025,
PUMA BIOTECHNOLOGY, INC. - Common Stock (PBYI) was held by
10 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
97,780 shares.
The largest 10 holders included
Baron Wealth Management LLC, Kathmere Capital Management, LLC, C2C Wealth Management, LLC, WEALTH ENHANCEMENT ADVISORY SERVICES, LLC, Rialto Wealth Management, LLC, NISA INVESTMENT ADVISORS, LLC, GAMMA Investing LLC, True Wealth Design, LLC, SJS Investment Consulting Inc., and ELEVATION WEALTH PARTNERS, LLC.
This page lists
10
institutional shareholders reporting positions in this security
for the Q4 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.